Skip to content
Apex Flow

Plan policy, Aetna, commercial plans

What Aetna's published policy says about Wegovy (semaglutide)

The documents Aetna publishes for Wegovy, linked to the plan's own pages, and what those documents list. Read through the free KAIS guide on November 4, 2026 for commercial plans; these are the documents the guide returns in each of the ten states checked: Arizona, California, Florida, Georgia, Illinois, New York, North Carolina, Ohio, Pennsylvania and Texas.

What the policy lists

Prior authorizationlisted in the policy
Quantity limitlisted in the policy

Aetna's documents for Wegovy

The plan's own lines

Quoted from the plan's document, word for word.

For pediatric obesity

Laboratory documentation

What this medicine is used for

“to reduce excess body weight and maintain weight reduction long term in: o Adults and pediatric patients aged 12 years and older with obesity o Adults with overweight in the presence of at least one weight-related comorbid condition”

From the FDA label for Wegovy, revised April 23, 2024. The label is shown in English as published. DailyMed. Your doctor decides what it is used for in your case.

Common questions

Does Aetna require prior authorization for Wegovy?

Aetna's published policy lists prior authorization for Wegovy.

Does Aetna have a quantity limit for Wegovy?

Aetna's published policy lists a quantity limit for Wegovy.

How do I see the policy for my own plan and state?

Open the free KAIS guide, pick your plan, your type of plan, your state and your medicine, and it shows the policy your plan publishes, with the link to the plan's own document.

Not medical advice and not a decision on your claim. Your doctor and your plan decide.